Catecholamine modulators: lessons from nonhuman primates.
Castellanos
F Xavier
FX
Kelly
Clare
C
D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use*; D000818:Animals; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000503:physiopathology*; D002395:Catecholamines / Q000502:physiology*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006801:Humans; D017397:Prefrontal Cortex / Q000187:drug effects / Q000503:physiopathology
D018759:Adrenergic Uptake Inhibitors; D002395:Catecholamines; D000697:Central Nervous System Stimulants